Cargando…
Poly-ADP-Ribosylation of Estrogen Receptor-Alpha by PARP1 Mediates Antiestrogen Resistance in Human Breast Cancer Cells
Therapeutic targeting of estrogen receptor-α (ERα) by the anti-estrogen tamoxifen is standard of care for premenopausal breast cancer patients and remains a key component of treatment strategies for postmenopausal patients. While tamoxifen significantly increases overall survival, tamoxifen resistan...
Autores principales: | Pulliam, Nicholas, Tang, Jessica, Wang, Weini, Fang, Fang, Sood, Riddhi, O’Hagan, Heather M., Miller, Kathy D., Clarke, Robert, Nephew, Kenneth P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357000/ https://www.ncbi.nlm.nih.gov/pubmed/30621214 http://dx.doi.org/10.3390/cancers11010043 |
Ejemplares similares
-
PARPs and ADP-ribosylation: 60 years on
por: Kraus, W. Lee
Publicado: (2020) -
PARP2 mediates branched poly ADP-ribosylation in response to DNA damage
por: Chen, Qian, et al.
Publicado: (2018) -
Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins
por: Alemasova, Elizaveta E, et al.
Publicado: (2019) -
Mono-ADP-ribosylation by PARP10 and PARP14 in genome stability
por: Dhoonmoon, Ashna, et al.
Publicado: (2023) -
In silico characterization of the family of PARP-like poly(ADP-ribosyl)transferases (pARTs)
por: Otto, Helge, et al.
Publicado: (2005)